Search Results
46 items found for "Renal transplantation"
- 📰 GPCR Weekly News, May 29 to June 4, 2023
GPCRs in Cardiology, Endocrinology, and Taste GPR97 deficiency ameliorates renal interstitial fibrosis Transcriptomic analysis of human cytomegalovirus to survey the indirect effects on renal transplant recipients
- A NanoBRET-Based H 3 R Conformational Biosensor to Study Real-Time H 3 Receptor Pharmacology in...
August 2022 A NanoBRET-Based H 3 R Conformational Biosensor to Study Real-Time H 3 Receptor Pharmacology
- RAB-Symposium - Regulatory Autoantibodies Targeting GPCRs. September 15-16, 2022. Lübeck, Germany...
on the role of autoantibodies targeting GPCRs in various diseases, such as cardiovascular diseases, renal
- TRPM3 in the eye and in the nervous system - from new findings to novel mechanisms
to be discussed and to be put in context as soon as possible to be up-to-date and to accelerate the translation
- Regulator of G Protein Signaling 20 Correlates with Long Intergenic Non-Coding RNA (lincRNAs)...
HCC (p < 0.001), RGS20 was found to be an important factor for survival in four other cancers (clear renal
- 📰 GPCR Weekly News - January 9 to 15, 2023
GPR97 deficiency ameliorates renal interstitial fibrosis in mouse hypertensive nephropathy. Molecular Pharmacology, Discovery Biology Staff Scientist/Senior Staff Scientist, Disease Biology and Translational
- 📰 GPCR Weekly News, June 5 to 11, 2023
Novartis bolsters innovative medicines strategy and renal pipeline with agreement to acquire Chinook
- 📰 GPCR Weekly News, January 29 to February 4, 2024
protein-coupled receptor GPR52 Endosome positioning coordinates spatially selective GPCR signaling GRK5 promoted renal
- Odorant receptors – a bit of smell for drug discovery
In the human kidney ORs elicit intracellular Ca2+flux in renal proximal tubule cells via adenylyl cyclase
- Targeting the M1 muscarinic receptor in neurodegenerative disease
April 2022 "By Sophie Bradley | Apr 12, 2022 Summary Sophie Bradley, Translational Sciences Associate
- Molecular insights into psychedelic drug action
August 2022 "A confluence of factors has renewed interest in the scientific understanding and translational
- Modulation of Striatal Adenosinergic Function by HTL0041178, a Selective GPR52 Agonist
April 2022 "By Cliona MacSweeney | Apr 20, 2022 Cliona MacSweeney, a project director in our Translational
- Emerging approaches for decoding neuropeptide transmission
Neuropeptides exhibit distinct characteristics which includes their post-translational processing, release
- Community guidelines for GPCR ligand bias: IUPHAR review 32
and should benefit from and contribute to the implementation of the guidelines, together improving translation
- Dopamine D 1 receptor-mediated β-arrestin signaling: Insight from pharmacology, biology, behavior...
We discuss the importance of understanding the translatability of cell and animal models to have more
- From DNA day to GPCR genomics
such as transcriptomics and proteomics have provided insights into the expression patterns and post-translational clinical research has opened new avenues for exploring GPCR biology, developing targeted therapies, and translating
- Mechanistic Understanding of the Palmitoylation of Go Protein in the Allosteric Regulation of...
Our study provides mechanistic insights into the regulation of aGPCRs via post-translational modifications
- Although the cannabinoid type-2 receptor (CB2) is highly expressed in the immune system, emerging...
While more work is needed to further elucidate the translational value of selectively targeting CB2 receptors
- Sosei Heptares Confirms Senior Leadership Changes to Drive the Company Through the Next Stage ...
"New team focused on expanding its GPCR-focused structure-based drug design platform and enhancing translational
- PAR-Induced Harnessing of EZH2 to β-Catenin: Implications for Colorectal Cancer
In addition, the molecular mechanisms underlying GPCR-induced post-translational signaling regulation
- Murine bone marrow macrophages and human monocytes do not express atypical chemokine receptor 1
Erythrocytes are terminally differentiated anuclear cells with no transcription and limited translation
- GPCRS: AN ODYSSEY FROM STRUCTURE, SIGNALING AND REGULATION TO THERAPEUTICS
challenges in the study of GPCR action in multiple systems, but also offers exciting opportunities in the translational
- 📢 GPCR Update: August 19-25, 2024 | Thrilling Announcement: New Pharmacology Course Dates & Exclusive Discounts Inside!
Topics cover new cellular assays, real-time kinetics, and unique GPCR behaviors. Special Issue of Molecular Pharmacology GPCR Events, Meetings, and Webinars September 5 - 6, 2024 | 4th Transatlantic
- 📰 GPCR Weekly News, August 7 to 13, 2023
GPCR Events, Meetings, and Webinars ONCORNET2.0 Final Symposium (August 31 - September 1, 2023) 3rd Transatlantic
- Do You Believe AI Could Accelerate Drug Discovery?
advanced AI models like AlphaFold3, which can predict complex protein-molecule interactions and post-translational
- 📰 GPCR Weekly News - January 2 to 8, 2023
Molecular Pharmacology, Discovery Biology Staff Scientist/Senior Staff Scientist, Disease Biology and Translational
- 📰 GPCR Weekly Buzz: Exciting Schedule Shifts for Principles of Pharmacology I & II | August 12-18, 2024
October 31, November 7 - 14 -21, and December 5, 2024 (five sessions) Topics: New cellular assays, real-time Possibilities in GLP-1R Drug Discovery GPCR Events, Meetings, and Webinars September 5 - 6, 2024 | 4th Transatlantic
- 📰 GPCR Buzz: August 5-11, 2024 | Top Highlights from DrGPCR University!
cellular assays to analyze GPCR ligand behavior Predicting activity and in vivo target coverage with real-time Intralinks’ Virtual Data Room GPCR Events, Meetings, and Webinars NEW September 5 - 6, 2024 | 4th Transatlantic